Investigating blood vessel characteristics in children
Official title: Study of the Characteristics of the Vascular Wall in Pediatric Age
Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774586 · Data updated 2026-11-12
This study is testing how the health of blood vessels in children and teens can affect their heart health later in life, using a special device to measure how stiff their arteries are.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years to 17 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Status | Recruiting |
| Started | June 18, 2024 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | January 14, 2025 |
| Trial ID | NCT06774586 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children and adolescents aged 6 to 17 who are being treated in pediatric emergency departments.
✕Probably not a fit
Patients with behavioral disorders, severe cognitive impairments, or anatomical issues that prevent proper examination may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the characteristics of the vascular wall and assess cardiovascular risk in children and adolescents, regardless of existing heart disease. Participants will undergo a noninvasive diagnostic examination using an innovative device called VICORDER© to measure arterial stiffness, a key risk factor for cardiovascular disease. The study seeks to understand how early vascular changes can influence cardiovascular health later in life, particularly in relation to common pediatric risk factors such as obesity and hypertension.
Why it matters
Potential benefit: If successful, this study could lead to early identification of cardiovascular risks in children, allowing for timely interventions.
How similar studies have gone: Other studies have recognized the importance of measuring arterial stiffness in pediatric populations, indicating a growing interest in this area, though this specific approach may be novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients from 6 to 17 years of age (extremes included) being treated in the Outpatient Departments of Emergency Pediatrics or admitted to the Department of Emergency Pediatrics * Patient cooperation during the performance of the examination. * Obtaining informed consent from the parent/legal guardian Exclusion Criteria: * Behavioral disorders or severe cognitive retardation, extreme agitation, or other factors that may impair the proper performance of the examination. * Anatomical alterations or presence of device or local pathology that conflicts with the placement of the VICORDER© cuffs.
Where it's running
-
IRCCS Azienda Ospedaliero - Universitaria di Bologna, U.O. Pediatria d'Urgenza, Pronto Soccorso e Osservazione Breve ed Intensiva
Bologna, Italy Recruiting
Study contacts
- Principal investigator: Marianna Fabi, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Marianna Fabi, MD
- Email: marianna.fabi@aosp.bo.it
- Phone: 0512143012
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
One-stop photon-counting CT for patients after PCI
This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.